Industry experts say the COVID-19 outbreak is unlikely to limit U.S. drug supplies in the short or middle term. However, they tell AIS Health that increased demand for longer-duration stocks of medication from self-isolating patients could strain supplies going forward.
To access this post, you must purchase a subscription plan. Click Here to purchase.

Already a member? Click Here to login.